Anti-ITAX/ ITGAX/ CD11C monoclonal antibody

Anti-ITAX/ ITGAX/ CD11C antibody for FACS & in-vivo assay

Target products collectionGo to ITGAX/ITGAX products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0638-Ab-1/ GM-Tg-hg-MP0638-Ab-2Anti-Human ITGAX monoclonal antibodyHuman
GM-Tg-rg-MP0638-Ab-1/ GM-Tg-rg-MP0638-Ab-2Anti-Rat ITGAX monoclonal antibodyRat
GM-Tg-mg-MP0638-Ab-1/ GM-Tg-mg-MP0638-Ab-2Anti-Mouse ITGAX monoclonal antibodyMouse
GM-Tg-cynog-MP0638-Ab-1/ GM-Tg-cynog-MP0638-Ab-2Anti-Cynomolgus/ Rhesus macaque ITGAX monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0638-Ab-1/ GM-Tg-felg-MP0638-Ab-2Anti-Feline ITGAX monoclonal antibodyFeline
GM-Tg-cang-MP0638-Ab-1/ GM-Tg-cang-MP0638-Ab-2Anti-Canine ITGAX monoclonal antibodyCanine
GM-Tg-bovg-MP0638-Ab-1/ GM-Tg-bovg-MP0638-Ab-2Anti-Bovine ITGAX monoclonal antibodyBovine
GM-Tg-equg-MP0638-Ab-1/ GM-Tg-equg-MP0638-Ab-2Anti-Equine ITGAX monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0638-Ab-1/ GM-Tg-hg-MP0638-Ab-2; GM-Tg-rg-MP0638-Ab-1/ GM-Tg-rg-MP0638-Ab-2;
GM-Tg-mg-MP0638-Ab-1/ GM-Tg-mg-MP0638-Ab-2; GM-Tg-cynog-MP0638-Ab-1/ GM-Tg-cynog-MP0638-Ab-2;
GM-Tg-felg-MP0638-Ab-1/ GM-Tg-felg-MP0638-Ab-2; GM-Tg-cang-MP0638-Ab-1/ GM-Tg-cang-MP0638-Ab-2;
GM-Tg-bovg-MP0638-Ab-1/ GM-Tg-bovg-MP0638-Ab-2; GM-Tg-equg-MP0638-Ab-1/ GM-Tg-equg-MP0638-Ab-2
Products NameAnti-ITGAX monoclonal antibody
Formatmab
Target NameITGAX
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ITGAX benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ITAX/ ITGAX/ CD11C VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0638
    Target NameITGAX
    Gene ID3687,16411,499271,100427850,489929,101087698,101904063,100064779
    Gene Symbol and SynonymsCD11C,Cr4,ITGAX,N418,RGD1561123,SLEB6
    Uniprot AccessionP20702
    Uniprot Entry NameITAX_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000140678
    Target ClassificationTumor-associated antigen (TAA)

    The target: ITGAX, gene name: ITGAX, also named as CD11C, SLEB6. This gene encodes the integrin alpha X chain protein. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. This protein combines with the beta 2 chain (ITGB2) to form a leukocyte-specific integrin referred to as inactivated-C3b (iC3b) receptor 4 (CR4). The alpha X beta 2 complex seems to overlap the properties of the alpha M beta 2 integrin in the adherence of neutrophils and monocytes to stimulated endothelium cells, and in the phagocytosis of complement coated particles. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.